Oisin Biotechnology is a leader in removing senescent cells for antiaging. They have shown p16 positive senescent cells can be killed on demand in both in vitro and in vivo environments. Now they have started on experiments that will show improvements in both healthspan and lifespan in model organisms from mice to primates. And then, everything changes.
The Oisin Biotechnologies staff are currently more than six months into a long-term mouse lifespan study, using cohorts in which the gene therapy is deployed against either p16, p53, or both p16 and p53, plus a control group injected with phosphate buffered saline (PBS). The study commenced more than six months ago with mice that were at the time two years (104 weeks) old.
So far half of the control group mice are dead but only 10% of the mice with both p16 and p53 gene therapy treatment are dead.
There is a 28 page presentation of the Oisin Biotechnologies work.
The Methuselah Foundation is trying to make 90 the new 50 by 2030.
Wang is a prolific business-oriented writer of emerging and disruptive technologies. He is known for insightful articles that combine business and technical analysis that catches the attention of the general public and is also useful for those in the industries. He is the sole author and writer of nextbigfuture.com
, the top online science blog. He is also involved in angel investing and raising funds for breakthrough technology startup companies.
He gave the recent keynote presentation at Monte Jade event with a talk entitled the Future for You. He gave an annual update on molecular nanotechnology at Singularity University on nanotechnology, gave a TEDX talk on energy, and advises USC ASTE 527 (advanced space projects program). He has been interviewed for radio, professional organizations. podcasts and corporate events. He was recently interviewed by the radio program Steel on Steel on satellites and high altitude balloons that will track all movement in many parts of the USA.
He fundraises for various high impact technology companies and has worked in computer technology, insurance, healthcare and with corporate finance.
He has substantial familiarity with a broad range of breakthrough technologies like age reversal and antiaging, quantum computers, artificial intelligence, ocean tech, agtech, nuclear fission, advanced nuclear fission, space propulsion, satellites, imaging, molecular nanotechnology, biotechnology, medicine, blockchain, crypto and many other areas.